Mohamed, Ruzianisra and Mohd Mutalip, Siti Syairah and Jalaludin, Nadia
(2024)
Elucidation of peptide inhibitors against human BAP1 using in-silico studies / Ruzianisra Mohamed, Siti Syairah Mohd Mutalip and Nadia Jalaludin.
Prescription (11).
Abstract
Breast cancer (BC) cases are rising globally at an alarming rate, making BC the leading cause of cancer-related deaths worldwide, including in Malaysia. In 2020 alone, the Global Cancer Observatory recorded 48,639 new cancer cases, with BC accounting for a significant 8,418 of these. Despite advancements in treatment, survival rates remain low due to factors like late detection, diagnostic delays, and limited access to proper treatment. Improving early detection and treatment accessibility is crucial, but given the persistence and severity of BC, new strategies are urgently needed.
Metadata
| Item Type: | Article |
|---|---|
| Creators: | Creators Email / ID Num. Mohamed, Ruzianisra UNSPECIFIED Mohd Mutalip, Siti Syairah UNSPECIFIED Jalaludin, Nadia UNSPECIFIED |
| Subjects: | R Medicine > RS Pharmacy and materia medica R Medicine > RS Pharmacy and materia medica > Materia medica |
| Divisions: | Universiti Teknologi MARA, Selangor > Puncak Alam Campus > Faculty of Pharmacy |
| Journal or Publication Title: | Prescription |
| Number: | 11 |
| Keywords: | peptide inhibitors, BAP1, in-silico studies |
| Date: | November 2024 |
| URI: | https://ir.uitm.edu.my/id/eprint/117964 |
- Edit Item
![[thumbnail of 117964.pdf]](https://ir.uitm.edu.my/style/images/fileicons/text.png)
